TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT PHARMACOKINETICS AND/OR SAFETY

TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT PHARMACOKINETICS AND/OR SAFETY

This liquid pharmaceutical preparation for subcutaneous administration in humans contains 28.2 µg of teriparatide or salt thereof (component 1) in terms of teriparatide in a single dose, wherein the concentration of component 1 is 80 to 240 µg/mL. This liquid pharmaceutical preparation has excellent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MIYABE, KOHEI, MATSUNAWA, YASUHIRO, OSE, ATSUSHI, YAMAMOTO, HIKARU, SATO, YUKI, KODAMA, TOSHIYUKI
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This liquid pharmaceutical preparation for subcutaneous administration in humans contains 28.2 µg of teriparatide or salt thereof (component 1) in terms of teriparatide in a single dose, wherein the concentration of component 1 is 80 to 240 µg/mL. This liquid pharmaceutical preparation has excellent pharmacodynamics. Cette préparation pharmaceutique liquide pour une administration sous-cutanée chez l'homme contient 28,2 µg de tériparatide ou d'un sel de celui-ci (constituant 1) en termes de tériparatide en une seule dose, la concentration du constituant 1 étant de 80 à 240 µg/mL. Cette préparation pharmaceutique liquide présente d'excellentes propriétés pharmacodynamiques.